Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Freshman Senator Jeanne Shaheen Is Long-Time Advocate Of Health Reform

Executive Summary

Incoming Senator Jeanne Shaheen will bring her long-time advocacy for increased access to less costly prescription drugs to the health reform debate in the 111 Congress

You may also be interested in...



PhRMA In The Game: Tauzin Pitches Universal Rx Coverage At Health Summit

Pharmaceutical Research and Manufacturers of America President Billy Tauzin got the opportunity to make a case for universal drug coverage to some key congressional and administration players at the White House forum on health reform March 5

PhRMA In The Game: Tauzin Pitches Universal Rx Coverage At Health Summit

Pharmaceutical Research and Manufacturers of America President Billy Tauzin got the opportunity to make a case for universal drug coverage to some key congressional and administration players at the White House forum on health reform March 5

HHS Secretary: Daschle Is Talking The Talk

Former Senate Majority Leader focuses on health care challenges facing the Obama administration during talk to Wall Street.

Topics

UsernamePublicRestriction

Register

OM017181

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel